15837-47-5

Upstream product

• 15886-45-0 6-amino-5-nitroso-1-phenyl-1,3-dihydropyrimidine-2,4-dione 
• 15837-45-3 6-amino-1-phenyluracil 

Downstream Products

• 110251-58-6 1-phenyl-1H,8H-pteridine-2,4,7-trione 
• 15837-51-1 3-Phenyl-8-mercaptoxanthine 
• 78241-64-2 1-phenyl-6,7-phenanthrenolumazine 
• 78251-51-1 1-phenyl-6,7-acenaphthenolumazine 
• 109187-19-1 7-methoxy-3-methyl-1-phenyl-1H-pteridine-2,4-dione 
• 108989-62-4 3-methyl-1-phenyl-1H,8H-pteridine-2,4,7-trione 
• 15837-48-6 3-phenyl-uric acid 
• 81960-58-9 3-Phenyl-1,7-diethyl-8-ethylmercaptoxanthine 
• 15836-91-6 3-Phenyl-8-methylmercaptoxanthine 
• 94591-17-0 1-Phenyl-7-propionyllumazin 

Relevant academic research and scientific papers

XANTHINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS

Disclosed are compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.

Structure and activity relationships of novel uracil derivatives as topical anti-inflammatory agents

In order to create novel, topical anti-inflammatory compounds exhibiting more potent activities than lead compound CX-659S (1), we designed and synthesized various derivatives of 1 focusing on the uracil N(1)- and N(3)-substituents, and evaluated their an

A2B adenosine receptor antagonists

Disclosed are novel compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.